89 results on '"Youhanna S"'
Search Results
2. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives
- Author
-
Youhanna, S., Kemas, A. M., Preiss, L., Zhou, Y., Shen, J. X., Caka, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, Reza Zandi, Lind, J. U., Sellgren, C. M., Lauschke, V. M., Youhanna, S., Kemas, A. M., Preiss, L., Zhou, Y., Shen, J. X., Caka, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, Reza Zandi, Lind, J. U., Sellgren, C. M., and Lauschke, V. M.
- Abstract
The number of successful drug development projects has been stagnant for decades despite major breakthroughs in chemistry, molecular biology, and genetics. Unreliable target identification and poor translatability of preclinical models have been identified as major causes of failure. To improve predictions of clinical efficacy and safety, interest has shifted to three-dimensional culture methods in which human cells can retain many physiologically and functionally relevant phenotypes for extended periods of time. Here, we review the state of the art of available organotypic culture techniques and critically review emerging models of human tissues with key importance for pharmacokinetics, pharmacodynamics, and toxicity. In addition, developments in bioprinting and microfluidic multiorgan cultures to emulate systemic drug disposition are summarized. We close by highlighting important trends regarding the fabrication of organotypic culture platforms and the choice of platform material to limit drug absorption and polymer leaching while supporting the phenotypic maintenance of cultured cells and allowing for scalable device fabrication. We conclude that organotypic and microphysiological human tissue models constitute promising systems to promote drug discovery and development by facilitating drug target identification and improving the preclinical evaluation of drug toxicity and pharmacokinetics. There is, however, a critical need for further validation, benchmarking, and consolidation efforts ideally conducted in intersectoral multicenter settings to accelerate acceptance of these novel models as reliable tools for translational pharmacology and toxicology. Significance Statement Organotypic and microphysiological culture of human cells has emerged as a promising tool for preclinical drug discovery and development that might be able to narrow the translation gap. This review discusses recent technological and methodological advancements and the use of these systems fo, QC 20221017
- Published
- 2022
- Full Text
- View/download PDF
3. Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity
- Author
-
Shen, J. X., Youhanna, S., Shafagh, Reza Zandi, Kele, J., Lauschke, V. M., Shen, J. X., Youhanna, S., Shafagh, Reza Zandi, Kele, J., and Lauschke, V. M.
- Abstract
Despite extensive breakthroughs in chemistry, molecular biology, and genetics in the last decades, the success rates of drug development projects remain low. To improve predictions of clinical efficacy and safety of new compounds, a plethora of 3D culture methods of human cells have been developed in which the cultured cells retain physiologically and functionally relevant phenotypes for multiple weeks. Here, we critically review current paradigms for organotypic cultures of human liver, gut, and kidney such as perfused microchips, spheroids, and hollow fiber bioreactors and discuss their utility for understanding drug pharmacokinetics, metabolism, and toxicity. Furthermore, bioprinting and the microfluidic integration of different tissue models to mimic systemic drug effects are highlighted as promising technological trends. In the last part of the review, we discuss important considerations regarding the choice of culture substratum material to limit adverse effects such as drug absorption while facilitating the phenotypic maintenance of cultured cells. We conclude that recent advances in organotypic and microphysiological culture models of human tissues can improve drug development and contribute to an amelioration of clinical attrition rates. However, further validation, benchmarking, and consolidation efforts are needed to achieve more widespread dissemination and eventually regulatory acceptance of these novel tools., QC 20200406
- Published
- 2020
- Full Text
- View/download PDF
4. Metabolic outcomes of laparoscopic sleeve gastrectomy
- Author
-
Hany Haroun Kaisar and Youhanna S. Shafik
- Subjects
03 medical and health sciences ,medicine.medical_specialty ,Laparoscopic sleeve gastrectomy ,0302 clinical medicine ,Hepatology ,business.industry ,Medicine ,030211 gastroenterology & hepatology ,030209 endocrinology & metabolism ,business ,Surgery - Published
- 2018
5. Clostridium perfringens: Insight into virulence evolution and population structure
- Author
-
Sawires, Youhanna S. and Songer, J. Glenn
- Published
- 2006
- Full Text
- View/download PDF
6. Multiple-locus variable-number tandem repeat analysis for strain typing of Clostridium perfringens
- Author
-
Sawires, Youhanna S. and Songer, J.Glenn
- Published
- 2005
- Full Text
- View/download PDF
7. Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study
- Author
-
Ponte B Pruijm M Ackermann D Vuistiner P Guessous I Ehret G Alwan H Youhanna S Paccaud F Mo
- Abstract
Arginine vasopressin (AVP) has a key role in osmoregulation by facilitating water transport in the collecting duct. Recent evidence suggests that AVP may have additional effects on renal function and favor cyst growth in polycystic kidney disease. Whether AVP also affects kidney structure in the general population is unknown. We analyzed the association of copeptin an established surrogate for AVP with parameters of renal function and morphology in a multicentric population based cohort. Participants from families of European ancestry were randomly selected in three Swiss cities. We used linear multilevel regression analysis to explore the association of copeptin with renal function parameters as well as kidney length and the presence of simple renal cysts assessed by ultrasound examination. Copeptin levels were log transformed. The 529 women and 481 men had median copeptin levels of 3.0 and 5.2 pmol/L respectively (P
- Published
- 2015
8. Genome-Wide Meta-Analysis Unravels Interactions between Magnesium Homeostasis and Metabolic Phenotypes.
- Author
-
Corre, T., Arjona, F.J., Hayward, C., Youhanna, S., Baaij, J.H.F. de, Belge, H., Nagele, N., Debaix, H., Blanchard, M.G., Traglia, M., Harris, S.E., Ulivi, S., Rueedi, R., Lamparter, D., Mace, A., Sala, C., Lenarduzzi, S., Ponte, B., Pruijm, M., Ackermann, D., Ehret, G., Baptista, D., Polasek, O., Rudan, I., Hurd, T.W., Hastie, N.D., Vitart, V., Waeber, G., Kutalik, Z., Bergmann, S., Vargas-Poussou, R., Konrad, M., Gasparini, P., Deary, I.J., Starr, J.M., Toniolo, D., Vollenweider, P., Hoenderop, J.G.J., Bindels, R.J.M., Bochud, M., Devuyst, O., Corre, T., Arjona, F.J., Hayward, C., Youhanna, S., Baaij, J.H.F. de, Belge, H., Nagele, N., Debaix, H., Blanchard, M.G., Traglia, M., Harris, S.E., Ulivi, S., Rueedi, R., Lamparter, D., Mace, A., Sala, C., Lenarduzzi, S., Ponte, B., Pruijm, M., Ackermann, D., Ehret, G., Baptista, D., Polasek, O., Rudan, I., Hurd, T.W., Hastie, N.D., Vitart, V., Waeber, G., Kutalik, Z., Bergmann, S., Vargas-Poussou, R., Konrad, M., Gasparini, P., Deary, I.J., Starr, J.M., Toniolo, D., Vollenweider, P., Hoenderop, J.G.J., Bindels, R.J.M., Bochud, M., and Devuyst, O.
- Abstract
1 januari 2018, Contains fulltext : 184156.pdf (publisher's version ) (Closed access), Magnesium (Mg(2+)) homeostasis is critical for metabolism. However, the genetic determinants of the renal handling of Mg(2+), which is crucial for Mg(2+) homeostasis, and the potential influence on metabolic traits in the general population are unknown. We obtained plasma and urine parameters from 9099 individuals from seven cohorts, and conducted a genome-wide meta-analysis of Mg(2+) homeostasis. We identified two loci associated with urinary magnesium (uMg), rs3824347 (P=4.4x10(-13)) near TRPM6, which encodes an epithelial Mg(2+) channel, and rs35929 (P=2.1x10(-11)), a variant of ARL15, which encodes a GTP-binding protein. Together, these loci account for 2.3% of the variation in 24-hour uMg excretion. In human kidney cells, ARL15 regulated TRPM6-mediated currents. In zebrafish, dietary Mg(2+) regulated the expression of the highly conserved ARL15 ortholog arl15b, and arl15b knockdown resulted in renal Mg(2+) wasting and metabolic disturbances. Finally, ARL15 rs35929 modified the association of uMg with fasting insulin and fat mass in a general population. In conclusion, this combined observational and experimental approach uncovered a gene-environment interaction linking Mg(2+) deficiency to insulin resistance and obesity.
- Published
- 2018
9. Invasive Blastocystis hominis infection in a child
- Author
-
Al-Tawil, Youhanna S., Gilger, Mark A., Gopalakrishna, G.S., Langston, Claire, and Bommer, K.E.
- Subjects
Intestines -- Microbiology ,Gastrointestinal diseases -- Causes of ,Health - Abstract
Blastocystis hominis, a protozoan organism, may be capable of causing human disease. A child with watery, blood-streaked stools was found on colonoscopy to have multiple superficial ulcerations of the colon. Microscope slides made from biopsies revealed the ulcerations contained numerous Blastocystis organisms as well as white blood cells indicative of inflammation. Salmonella, Shigella, Yersinia, Campylobacter, and Clostridium difficile were ruled out. Oral metronidazole effected a cure. The pathogenic capabilities of this parasite have been debated. It is frequently found in human stool samples where there is no evidence of disease, and where it is found in conjunction with disease, other possible causes have been found as well.
- Published
- 1994
10. Supplementary Material for: Validation of Surrogates of Urine Osmolality in Population Studies
- Author
-
Youhanna, S., Bankir, L., Jungers, P., Porteous, D., Polasek, O., Bochud, M., Hayward, C., and Devuyst, O.
- Subjects
fungi - Abstract
Background: The importance of vasopressin and/or urine concentration in various kidney, cardiovascular, and metabolic diseases has been emphasized recently. Due to technical constraints, urine osmolality (Uosm), a direct reflect of urinary concentrating activity, is rarely measured in epidemiologic studies. Methods: We analyzed 2 possible surrogates of Uosm in 4 large population-based cohorts (total n = 4,247) and in patients with chronic kidney disease (CKD, n = 146). An estimated Uosm (eUosm) based on the concentrations of sodium, potassium, and urea, and a urine concentrating index (UCI) based on the ratio of creatinine concentrations in urine and plasma were compared to the measured Uosm (mUosm). Results: eUosm is an excellent surrogate of mUosm, with a highly significant linear relationship and values within 5% of mUosm (r = 0.99 or 0.98 in each population cohort). Bland-Altman plots show a good agreement between eUosm and mUosm with mean differences between the 2 variables within ±24 mmol/L. This was verified in men and women, in day and night urine samples, and in CKD patients. The relationship of UCI with mUosm is also significant but is not linear and exhibits more dispersed values. Moreover, the latter index is no longer representative of mUosm in patients with CKD as it declines much more quickly with declining glomerular filtration rate than mUosm. Conclusion: The eUosm is a valid marker of urine concentration in population-based and CKD cohorts. The UCI can provide an estimate of urine concentration when no other measurement is available, but should be used only in subjects with normal renal function.
- Published
- 2017
- Full Text
- View/download PDF
11. Shared genetic variants between serum levels of high-density lipoprotein cholesterol and wheezing in a cohort of children from Cyprus
- Author
-
Yiallouros, Panayiotis K., Kouis, Panayiotis, Kolokotroni, Ourania, Youhanna, S., Savva, Savvas C., Dima, Kleanthi, Zerva, A., Platt, D., Middleton, Nicos, Zalloua, P., Yiallouros, Panayiotis K. [0000-0002-8339-9285], Kolokotroni, Ourania [0000-0002-7653-002X], Dima, Kleanthi [0000-0001-5284-115X], and Kouis, Panayiotis [0000-0003-0511-5352]
- Subjects
0301 basic medicine ,Male ,Protein Kinase C-alpha ,Adolescent ,Genotype ,Genotypes ,Single-nucleotide polymorphism ,030204 cardiovascular system & hematology ,Polymorphism, Single Nucleotide ,Risk Assessment ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,High-density lipoprotein ,Polymorphism (computer science) ,Risk Factors ,MEDICAL AND HEALTH SCIENCES ,Genetic variation ,Medicine ,Humans ,Children ,High density lipoprotein cholesterol ,Asthma ,Respiratory Sounds ,business.industry ,Tumor Necrosis Factor-alpha ,Research ,Cholesterol, HDL ,Genetic Variation ,medicine.disease ,Obesity ,030104 developmental biology ,chemistry ,Cohort ,Immunology ,Cyprus ,Female ,business ,Polymorphisms - Abstract
Background In a cohort of children in Cyprus, we recently reported low levels of high density lipoprotein cholesterol (HDL-C) to be associated with asthma. We examined whether genetic polymorphisms that were previously linked individually to asthma, obesity, or HDL-C are associated with both asthma and HDL-C levels in the Cyprus cohort. Methods We assessed genotypes frequencies in current-wheezers (n = 190) and non-asthmatic controls (n = 671) and HDL-C levels across several genotypes. Binary logistic regression models were used to assess the effect of genotypes on wheezing risk and examined whether this effect is carried out through changes of HDL–C. Results Of the 16 polymorphisms tested, two polymorphisms TNFa rs3093664 and PRKCA rs9892651 presented significant differences in genotype distribution among current-wheezers and controls. Higher HDL-C levels were noted in carriers of genotype GG of polymorphism TNFa rs3093664 that was protective for wheezing Vs AG and AA genotypes (65.3 Vs 51.8 and 53.3 mg/dl, p-value
- Published
- 2016
12. Apolipoprotein B Is an Innate Barrier against Invasive Staphylococcus aureus Infection
- Author
-
Erin K. Sully, M. Michal Peterson, Susan M. Alexander, Anny A. Alsup, Michael Otto, Youhanna S. Sawires, Jessica L. Mack, Pamela R. Hall, Ambrose L. Cheung, and Hattie D. Gresham
- Subjects
Staphylococcus aureus ,Cancer Research ,Very low-density lipoprotein ,MICROBIO ,Apolipoprotein B ,Plasma protein binding ,medicine.disease_cause ,Staphylococcal infections ,Microbiology ,Pheromones ,Mice ,Bacterial Proteins ,Immunology and Microbiology(all) ,Virology ,medicine ,Animals ,Humans ,Receptor ,Lung ,Molecular Biology ,Apolipoproteins B ,Mice, Knockout ,biology ,Effector ,Body Weight ,Staphylococcal Infections ,medicine.disease ,Survival Analysis ,Phenotype ,SIGNALING ,Carrier State ,Immunology ,Trans-Activators ,biology.protein ,CELLBIO ,lipids (amino acids, peptides, and proteins) ,Parasitology ,Protein Kinases ,Gene Deletion ,Spleen ,Protein Binding - Abstract
SummaryStaphylococcus aureus is both a colonizer of humans and a cause of severe invasive infections. Although the genetic basis for phenotype switching from colonizing to invasive has received significant study, knowledge of host factors that antagonize the switch is limited. We show that VLDL and LDL lipoproteins interfere with this switch by antagonizing the S. aureus agr quorum-sensing system that upregulates genes required for invasive infection. The mechanism of antagonism entails binding of the major structural protein of these lipoproteins, apolipoprotein B, to an S. aureus autoinducing pheromone, preventing attachment of this pheromone to the bacteria and subsequent signaling through its receptor, AgrC. Mice deficient in plasma apolipoprotein B, either genetically or pharmacologically, are more susceptible to invasive agr+ bacterial infection, but not to infection with an agr deletion mutant. Therefore, apolipoprotein B at homeostatic levels in blood is an essential innate defense effector against invasive S. aureus infection.
- Published
- 2008
13. Clostridium perfringens: insight into virulence evolution and population structure
- Author
-
Youhanna S. Sawires and J. Glenn Songer
- Subjects
Genotype ,Clostridium perfringens ,Population ,Bacterial Toxins ,Virulence ,Minisatellite Repeats ,Biology ,medicine.disease_cause ,Microbiology ,Genome ,Phylogenetics ,medicine ,Animals ,Humans ,Selection, Genetic ,education ,Gene ,Pathogen ,Phylogeny ,Genetics ,education.field_of_study ,Phylogenetic tree ,Genetic Variation ,Biological Evolution ,Infectious Diseases ,Vertebrates - Abstract
Clostridium perfringens is an important pathogen in veterinary and medical fields. Diseases caused by this organism are in many cases life threatening or fatal. At the same time, it is part of the ecological community of the intestinal tract of man and animals. Virulence in this species is not fully understood and it does seem that there is erratic distribution of the toxin/enzyme genes within C. perfringens population. We used the recently developed multiple-locus variable-number tandem repeat analysis (MLVA) scheme to investigate the evolution of virulence and population structure of this species. Analysis of the phylogenetic signal indicates that acquisition of the major toxin genes as well as other plasmid-borne toxin genes is a recent evolutionary event and their maintenance is essentially a function of the selective advantage they confer in certain niches under different conditions. In addition, it indicates the ability of virulent strains to cause disease in different host species. More interestingly, there is evidence that certain normal flora strains are virulent when they gain access to a different host species. Analysis of the population structure indicates that recombination events are the major tool that shapes the population and this panmixia is interrupted by frequent clonal expansion that mostly corresponds to disease processes. The signature of positive selection was detected in alpha toxin gene, suggesting the possibility of adaptive alleles on the other chromosomally encoded determinants. Finally, C. perfringens proved to have a dynamic population and availability of more genome sequences and use of comparative proteomics and animal modeling would provide more insight into the virulence of this organism.
- Published
- 2005
14. Multiple-locus variable-number tandem repeat analysis for strain typing of Clostridium perfringens
- Author
-
Youhanna S. Sawires and J. Glenn Songer
- Subjects
Genetics ,Biology ,Multiple Loci VNTR Analysis ,Clostridium perfringens ,bacterial infections and mycoses ,medicine.disease_cause ,Microbiology ,Sudden death ,Enterotoxemia ,Variable number tandem repeat ,Infectious Diseases ,Tandem repeat ,Genotype ,medicine ,Typing - Abstract
Clostridium perfringens is ubiquitous in the environment and causes diseases in man and animals, with syndromes ranging from enteritis, enterotoxemia, and sudden death to food poisoning and gas gangrene. Understanding the epidemiology of these infections and of the evolution of virulence in C. perfringens necessitate an efficient, time and cost effective strain typing method. Multiple-locus variable-number tandem repeat analysis (MLVA) has been applied to typing of other pathogens and we describe here the development of a MLVA scheme for C. perfringens. We characterized five variable tandem repeat (VNTR) loci, four of which are contained within protein encoding genes and screened 112 C. perfringens isolates to evaluate typability, reproducibility, and discriminatory power of the scheme. All the isolates were assigned a MLVA genotype and the technique has excellent reproducibility, with a numerical index of discrimination for the five VNTR loci of 0.995. Thus MLVA is an efficient tool for C. perfringens strain typing, and being PCR based makes it rapid, easy, and cost effective. In addition, it can be employed in epidemiological, ecological, and evolutionary investigations of the organism.
- Published
- 2004
15. Comparison between butterfly gastroplasty (a new modified gastroplasty technique) and sleeve gastrectomy
- Author
-
AS, Elsobky, primary, Anas, Mashaal, additional, Mahfous, Mohammed, additional, Marzouk, M.A, additional, Shafik, Youhanna S., additional, and Abdelhalim, Sherif, additional
- Published
- 2014
- Full Text
- View/download PDF
16. Percutaneous liver biopsy in children: impact of ultrasonography and spring-loaded biopsy needles
- Author
-
Jose M. Barrios, Youhanna S. Al-Tawil, Mark A. Gilger, Ann O. Scheimann, and Krista M. Gray
- Subjects
Adult ,Male ,medicine.medical_specialty ,Percutaneous ,Adolescent ,medicine.medical_treatment ,Hemorrhage ,Hematocrit ,Liver transplantation ,Hemoglobins ,Risk Factors ,Internal medicine ,Biopsy ,medicine ,Humans ,Child ,Retrospective Studies ,Ultrasonography ,medicine.diagnostic_test ,Equipment Safety ,business.industry ,Incidence ,Liver Diseases ,Biopsy, Needle ,Gastroenterology ,Age Factors ,Infant ,Hepatology ,Surgery ,Liver Transplantation ,Liver ,Needles ,Liver biopsy ,Cryoprecipitate ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Female ,Radiology ,Blood Coagulation Tests ,business ,Complication - Abstract
Background: Percutaneous liver biopsy is a valued tool of pediatric hepatology. Recent advances in technology have incorporated spring-loaded biopsy needles and ultrasonography in percutaneous liver biopsy. Methods: To determine the frequency of complications after liver biopsy and whether variables such as needle selections (Jamshidi, Monopty, or ASAP) and ultrasound guidance could predict complications, medical records were retrospectively reviewed of all patients who underwent percutaneous liver biopsy during a 7-year period. Available data were collected from 123 patients who had undergone a total of 249 percutaneous liver biopsies. All patients with evidence of mild clotting abnormalities (8.83%) received platelets, cryoprecipitate, or fresh-frozen plasma. Results: There was a 6.83% incidence of overall complications, and a 2.4% incidence of major complications. The mortality rate was 0.4%. Ultrasound localization did not diminish the risk of bleeding during biopsy. There was no significant difference in the change of hematocrit between the aspiration (Jamshidi) and spring-loaded (Monopty) needles. However, in patients less than 5 years of age, the change of hematocrit was significantly higher (P < 0.05) with the 15- or 18-gauge ASAP needle (Microvasive, Quincy, MA, U.S.A.) than with either the Jamshidi (Allegience Healthcare, Columbia, MD, U.S.A.) or Monopty (Bard Technologies, Covington, GA, U.S.A.) needles. Conclusion: Percutaneous liver biopsy is safe, using either aspiration or spring-loaded needles. Ultrasound guidance may not be helpful except in patients who underwent segmental liver transplantation.
- Published
- 2001
17. Association of calcium-sensing receptor polymorphisms with indices of vascular calcification in renal transplant recipients
- Author
-
Babinsky, V.N., primary, Hannan, F.M., additional, Youhanna, S., additional, Devuyst, O., additional, and Thakker, R.V., additional
- Published
- 2012
- Full Text
- View/download PDF
18. S1076 Gene Expression Profile of Inflammatory Mediators and Extracellular Matrix and Adhesion Molecules in Eosinophilic Esophagitis
- Author
-
Abdulnour-Nakhoul, Solange M., primary, Al-Tawil, Youhanna S., additional, Eidelwein, Alexandra P., additional, Noel, Robert A., additional, Hansen, Molly, additional, Gyftopoulos, Alex A., additional, Butcher, Kathy F., additional, Brown, Karen L., additional, and Nakhoul, Nazih, additional
- Published
- 2010
- Full Text
- View/download PDF
19. Apolipoprotein B Is an Innate Barrier against Invasive Staphylococcus aureus Infection
- Author
-
Peterson, M. Michal, primary, Mack, Jessica L., additional, Hall, Pamela R., additional, Alsup, Anny A., additional, Alexander, Susan M., additional, Sully, Erin K., additional, Sawires, Youhanna S., additional, Cheung, Ambrose L., additional, Otto, Michael, additional, and Gresham, Hattie D., additional
- Published
- 2008
- Full Text
- View/download PDF
20. Percutaneous Liver Biopsy in Children: Impact of Ultrasonography and Spring‐Loaded Biopsy Needles
- Author
-
Scheimann, Ann O., primary, Barrios, Jose M., additional, Al‐Tawil, Youhanna S., additional, Gray, Krista M., additional, and Gilger, Mark A., additional
- Published
- 2000
- Full Text
- View/download PDF
21. Plasma myeloperoxidase concentration predicts the presence and severity of coronary disease in patients with chest pain and negative troponin-T.
- Author
-
Rebeiz AG, Tamim HM, Sleiman RM, Abchee AG, Ibrahim Z, Khoury MY, Youhanna S, Skouri HN, and Alam SE
- Published
- 2011
- Full Text
- View/download PDF
22. The I allele of the angiotensin converting enzyme I/D polymorphism confers protection against coronary artery disease.
- Author
-
Abchee A, El-Sibai M, Youhanna S, Yeretzian JS, Estephan H, Makhoul NJ, Puzantian H, Sawaya J, Nasrallah A, Rebeiz AG, Zreik TG, Azar ST, Zalloua PA, Abchee, Antoine, El-Sibai, Mirvat, Youhanna, Sonia, Yeretzian, Joumana S, Estephan, Hanine, Makhoul, Nadine J, and Puzantian, Houry
- Published
- 2010
- Full Text
- View/download PDF
23. Association of coronary artery disease and chronic kidney disease in Lebanese population
- Author
-
Aline Milane, Khazen, G., Zeineddine, N., Amro, M., Masri, L., Ghassibe-Sabbagh, M., Youhanna, S., Salloum, A. K., Haber, M., Platt, D. E., Cazier, J. -B, Othman, R., Kabbani, S., Sbeite, H., Chami, Y., Chammas, E., El Bayeh, H., Gauguier, D., Abchee, A. B., Zalloua, P., and Barbari, A.
- Subjects
Original Article - Abstract
Background: More evidence is emerging on the strong association between chronic kidney disease (CKD) and cardiovascular disease. We assessed the relationship between coronary artery disease (CAD) and renal dysfunction level (RDL) in a group of Lebanese patients. Methods: A total of 1268 patients undergoing cardiac catheterization were sequentially enrolled in a multicenter cross sectional study. Angiograms were reviewed and CAD severity scores (CADSS) were determined. Estimated glomerular filtration rate (eGFR) was calculated and clinical and laboratory data were obtained. CKD was defined as eGFR < 60 ml/min. Logistic regression model was performed using multivariate analysis including all traditional risk factors associated with both diseases. ANOVA and the Tukeytestswere used to compare subgroups of patients and to assess the impact of each disease on the severity of the other. Results: Among the 82% patients who exhibited variable degrees of CAD, 20.6% had an eGFR < 60 ml/min. Logistic regression analysis revealed a bidirectional independent association between CAD and CKD with an OR = 2.01 (P < 0.01) and an OR = 1.99 (P < 0.01) for CAD and CKD frequencies, respectively. We observed a steady increase in the CADSS mean as eGFR declined and a progressive reduction in renal function with the worsening of CAD (P < 0.05). This correlation remained highly significant despite considerable inter-patient variability and was at its highest at the most advanced stages of both diseases. Conclusions: Our results show a strong, independent and graded bidirectional relationship between CAD severity and RDL. We propose to add CAD to the list of risk factors for the development and progression of CKD.
24. Response to Giem.
- Author
-
Haber, M., Doumet-Serhal, C., Scheib, C., Xue, Y., Danecek, P., Mezzavilla, M., Youhanna, S., Martiniano, R., Prado-Martinez, J., Szpak, M., Matisoo-Smith, E., Schutkowski, Holger, Mikulski, R., Zalloua, P., Kivisild, T., Tyler-Smith, C., Haber, M., Doumet-Serhal, C., Scheib, C., Xue, Y., Danecek, P., Mezzavilla, M., Youhanna, S., Martiniano, R., Prado-Martinez, J., Szpak, M., Matisoo-Smith, E., Schutkowski, Holger, Mikulski, R., Zalloua, P., Kivisild, T., and Tyler-Smith, C.
25. Common Variants in UMOD Associate with Urinary Uromodulin Levels: A Meta-Analysis
- Author
-
Caroline S. Fox, Luca Rampoldi, Dragana Vuckovic, Giorgia Girotto, Sven Bergmann, Paolo Gasparini, Zoltán Kutalik, Peter Vollenweider, Sonia Youhanna, Johannes Loffing, Ozren Polasek, Shih-Jen Hwang, Daniela Toniolo, Julien Weber, Igor Rudan, Cinzia Sala, Sheila Ulivi, Michela Traglia, Bob Glaudemans, Olivier Devuyst, Nicholas D. Hastie, Ilaria Gandin, Massimiliano Cocca, Giorgio Pistis, Matthias Olden, Harry Campbell, Murielle Bochud, Caroline Hayward, Tanguy Corre, Alan F. Wright, Olden, M, Corre, T, Hayward, C, Toniolo, D, Ulivi, S, Gasparini, Paolo, Pistis, G, Hwang, Sj, Bergmann, S, Campbell, H, Cocca, Massimiliano, Gandin, Ilaria, Girotto, Giorgia, Glaudemans, B, Hastie, Nd, Loffing, J, Polasek, O, Rampoldi, L, Rudan, I, Sala, C, Traglia, Michela, Vollenweider, P, Vuckovic, Dragana, Youhanna, S, Weber, J, Wright, Af, Kutalik, Z, Bochud, M, Fox, C, Devuyst, O., Gasparini, P, Cocca, M, Gandin, I, Girotto, G, Traglia, M, Vuckovic, D, Devuyst, O, University of Zurich, and Devuyst, Olivier
- Subjects
Tamm–Horsfall protein ,10017 Institute of Anatomy ,uromodulin ,Urinary system ,SORL1 ,Population ,Renal function ,Single-nucleotide polymorphism ,610 Medicine & health ,Polymorphism, Single Nucleotide ,White People ,10052 Institute of Physiology ,chemistry.chemical_compound ,Humans ,Allele ,education ,Genetics ,Creatinine ,education.field_of_study ,2727 Nephrology ,biology ,Genetic Variation ,General Medicine ,chemistry ,Nephrology ,10076 Center for Integrative Human Physiology ,biology.protein ,570 Life sciences ,Meta-Analysis - Abstract
Uromodulin is expressed exclusively in the thick ascending limb and is the most abundant protein excreted in normal urine. Variants in UMOD, which encodes uromodulin, are associated with renal function, and urinary uromodulin levels may be a biomarker for kidney disease. However, the genetic factors regulating uromodulin excretion are unknown. We conducted a meta-analysis of urinary uromodulin levels to identify associated common genetic variants in the general population. We included 10,884 individuals of European descent from three genetic isolates and three urban cohorts. Each study measured uromodulin indexed to creatinine and conducted linear regression analysis of approximately 2.5 million single nucleotide polymorphisms using an additive model. We also tested whether variants in genes expressed in the thick ascending limb associate with uromodulin levels. rs12917707, located near UMOD and previously associated with renal function and CKD, had the strongest association with urinary uromodulin levels (P
- Published
- 2014
26. Crimean-Congo haemorrhagic fever virus uses LDLR to bind and enter host cells.
- Author
-
Monteil VM, Wright SC, Dyczynski M, Kellner MJ, Appelberg S, Platzer SW, Ibrahim A, Kwon H, Pittarokoilis I, Mirandola M, Michlits G, Devignot S, Elder E, Abdurahman S, Bereczky S, Bagci B, Youhanna S, Aastrup T, Lauschke VM, Salata C, Elaldi N, Weber F, Monserrat N, Hawman DW, Feldmann H, Horn M, Penninger JM, and Mirazimi A
- Subjects
- Animals, Humans, Mice, Mice, Knockout, Receptors, Virus metabolism, Ticks virology, Ticks metabolism, Apolipoproteins E metabolism, Apolipoproteins E genetics, Hemorrhagic Fever Virus, Crimean-Congo genetics, Hemorrhagic Fever Virus, Crimean-Congo physiology, Hemorrhagic Fever, Crimean virology, Hemorrhagic Fever, Crimean metabolism, Receptors, LDL metabolism, Receptors, LDL genetics, Virus Internalization
- Abstract
Climate change and population densities accelerated transmission of highly pathogenic viruses to humans, including the Crimean-Congo haemorrhagic fever virus (CCHFV). Here we report that the Low Density Lipoprotein Receptor (LDLR) is a critical receptor for CCHFV cell entry, playing a vital role in CCHFV infection in cell culture and blood vessel organoids. The interaction between CCHFV and LDLR is highly specific, with other members of the LDLR protein family failing to bind to or neutralize the virus. Biosensor experiments demonstrate that LDLR specifically binds the surface glycoproteins of CCHFV. Importantly, mice lacking LDLR exhibit a delay in CCHFV-induced disease. Furthermore, we identified the presence of Apolipoprotein E (ApoE) on CCHFV particles. Our findings highlight the essential role of LDLR in CCHFV infection, irrespective of ApoE presence, when the virus is produced in tick cells. This discovery holds profound implications for the development of future therapies against CCHFV., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
27. Consequences of Amyloid-β Deficiency for the Liver.
- Author
-
Buniatian GH, Schwinghammer U, Tremmel R, Cynis H, Weiss TS, Weiskirchen R, Lauschke VM, Youhanna S, Ramos I, Valcarcel M, Seferyan T, Rahfeld JU, Rieckmann V, Klein K, Buadze M, Weber V, Kolak V, Gebhardt R, Friedman SL, Müller UC, Schwab M, and Danielyan L
- Subjects
- Animals, Humans, Mice, Disease Models, Animal, Mice, Inbred C57BL, Mice, Knockout, Alzheimer Disease metabolism, Alzheimer Disease genetics, Alzheimer Disease pathology, Amyloid beta-Peptides metabolism, Amyloid beta-Peptides genetics, Liver metabolism, Liver pathology, Mice, Transgenic
- Abstract
The hepatic content of amyloid beta (Aβ) decreases drastically in human and rodent cirrhosis highlighting the importance of understanding the consequences of Aβ deficiency in the liver. This is especially relevant in view of recent advances in anti-Aβ therapies for Alzheimer's disease (AD). Here, it is shown that partial hepatic loss of Aβ in transgenic AD mice immunized with Aβ antibody 3D6 and its absence in amyloid precursor protein (APP) knockout mice (APP-KO), as well as in human liver spheroids with APP knockdown upregulates classical hallmarks of fibrosis, smooth muscle alpha-actin, and collagen type I. Aβ absence in APP-KO and deficiency in immunized mice lead to strong activation of transforming growth factor-β (TGFβ), alpha secretases, NOTCH pathway, inflammation, decreased permeability of liver sinusoids, and epithelial-mesenchymal transition. Inversely, increased systemic and intrahepatic levels of Aβ42 in transgenic AD mice and neprilysin inhibitor LBQ657-treated wild-type mice protect the liver against carbon tetrachloride (CCl
4 )-induced injury. Transcriptomic analysis of CCl4 -treated transgenic AD mouse livers uncovers the regulatory effects of Aβ42 on mitochondrial function, lipid metabolism, and its onco-suppressive effects accompanied by reduced synthesis of extracellular matrix proteins. Combined, these data reveal Aβ as an indispensable regulator of cell-cell interactions in healthy liver and a powerful protector against liver fibrosis., (© 2024 The Authors. Advanced Science published by Wiley‐VCH GmbH.)- Published
- 2024
- Full Text
- View/download PDF
28. 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation.
- Author
-
Wesseler MF, Taebnia N, Harrison S, Youhanna S, Preiss LC, Kemas AM, Vegvari A, Mokry J, Sullivan GJ, Lauschke VM, and Larsen NB
- Subjects
- Humans, Oxygen metabolism, Hydrogels metabolism, Liver, Hepatocytes metabolism
- Abstract
Hepatic in vitro models that accurately replicate phenotypes and functionality of the human liver are needed for applications in toxicology, pharmacology and biomedicine. Notably, it has become clear that liver function can only be sustained in 3D culture systems at physiologically relevant cell densities. Additionally, drug metabolism and drug-induced cellular toxicity often follow distinct spatial micropatterns of the metabolic zones in the liver acinus, calling for models that capture this zonation. We demonstrate the manufacture of accurate liver microphysiological systems (MPS) via engineering of 3D stereolithography printed hydrogel chips with arrays of diffusion open synthetic vasculature channels at spacings approaching in vivo capillary distances. Chip designs are compatible with seeding of cell suspensions or preformed liver cell spheroids. Importantly, primary human hepatocytes (PHH) and hiPSC-derived hepatocyte-like cells remain viable, exhibit improved molecular phenotypes compared to isogenic monolayer and static spheroid cultures and form interconnected tissue structures over the course of multiple weeks in perfused culture. 3D optical oxygen mapping of embedded sensor beads shows that the liver MPS recapitulates oxygen gradients found in the acini, which translates into zone-specific acet-ami-no-phen toxicity patterns. Zonation, here naturally generated by high cell densities and associated oxygen and nutrient utilization along the flow path, is also documented by spatial proteomics showing increased concentration of periportal- versus perivenous-associated proteins at the inlet region and vice versa at the outlet region. The presented microperfused liver MPS provides a promising platform for the mesoscale culture of human liver cells at phenotypically relevant densities and oxygen exposures. STATEMENT OF SIGNIFICANCE: A full 3D tissue culture platform is presented, enabled by massively parallel arrays of high-resolution 3D printed microperfusion hydrogel channels that functionally mimics tissue vasculature. The platform supports long-term culture of liver models with dimensions of several millimeters at physiologically relevant cell densities, which is difficult to achieve with other methods. Human liver models are generated from seeded primary human hepatocytes (PHHs) cultured for two weeks, and from seeded spheroids of hiPSC-derived human liver-like cells cultured for two months. Both model types show improved functionality over state-of-the-art 3D spheroid suspensions cultured in parallel. The platform can generate physiologically relevant oxygen gradients driven by consumption rather than supply, which was validated by visualization of embedded oxygen-sensitive microbeads, which is exploited to demonstrate zonation-specific toxicity in PHH liver models., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Lena C. Preiss reports financial support was provided by Merck KGaA. Volker M. Lauschke reports a relationship with HepaPredict AB and PersoMedix AB that includes: employment and equity or stocks. Voler M. Lauschke reports a relationship with Enginzyme AB that includes: consultancy., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
29. Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections.
- Author
-
Monteil V, Kwon H, John L, Salata C, Jonsson G, Vorrink SU, Appelberg S, Youhanna S, Dyczynski M, Leopoldi A, Leeb N, Volz J, Hagelkruys A, Kellner MJ, Devignot S, Michlits G, Foong-Sobis M, Weber F, Lauschke VM, Horn M, Feldmann H, Elling U, Penninger JM, and Mirazimi A
- Subjects
- Animals, Humans, Lysosomes, Ebolavirus metabolism, Hemorrhagic Fever, Ebola, Marburg Virus Disease genetics, Marburg Virus Disease metabolism, Marburgvirus metabolism, Vesicular Transport Proteins metabolism, Guanine Nucleotide Exchange Factors metabolism
- Abstract
Marburg and Ebola filoviruses are two of the deadliest infectious agents and several outbreaks have occurred in the last decades. Although several receptors and co-receptors have been reported for Ebola virus, key host factors remain to be elucidated. In this study, using a haploid cell screening platform, we identify the guanine nucleotide exchange factor CCZ1 as a key host factor in the early stage of filovirus replication. The critical role of CCZ1 for filovirus infections is validated in 3D primary human hepatocyte cultures and human blood-vessel organoids, both critical target sites for Ebola and Marburg virus tropism. Mechanistically, CCZ1 controls early to late endosomal trafficking of these viruses. In addition, we report that CCZ1 has a role in the endosomal trafficking of endocytosis-dependent SARS-CoV-2 infections, but not in infections by Lassa virus, which enters endo-lysosomal trafficking at the late endosome stage. Thus, we have identified an essential host pathway for filovirus infections in cell lines and engineered human target tissues. Inhibition of CCZ1 nearly completely abolishes Marburg and Ebola infections. Thus, targeting CCZ1 could potentially serve as a promising drug target for controlling infections caused by various viruses, such as SARS-CoV-2, Marburg, and Ebola., (© 2023. Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
30. Calcium measurements in enzymatically dissociated or mechanically microdissected mouse primary skeletal muscle fibers.
- Author
-
Youhanna S, Bruton J, Jardemark K, Westerblad H, and Lauschke VM
- Abstract
Here, we provide a protocol for isolation of mouse primary skeletal muscle fibers using two alternative approaches-enzymatic dissociation or mechanical microdissection. We describe the procedures for surgical removal of muscle of interest and isolation of intact single-muscle fibers by either collagenase digestion or mechanical microdissection. We then detail intracellular calcium measurements by microinjecting or loading the isolated muscle fibers with membrane permeable calcium dyes. Finally, we outline steps for intracellular calcium quantification by fluorescent measurement. For complete details on the use and execution of this protocol, please refer to Gineste et al.
1 ., Competing Interests: Declaration of interests V.M.L. is the CEO and a shareholder of HepaPredict AB, as well as a co-founder and shareholder of PersoMedix AB., (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
31. Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum.
- Author
-
Tredup C, Ndreshkjana B, Schneider NS, Tjaden A, Kemas AM, Youhanna S, Lauschke VM, Berger BT, Krämer A, Berger LM, Röhm S, Knapp S, Farin HF, and Müller S
- Subjects
- Humans, Liver, Microphysiological Systems, Organoids metabolism, Organoids pathology, Proteins metabolism, Neoplasms metabolism, Small Molecule Libraries classification, Molecular Probes chemistry, Molecular Probes pharmacology
- Abstract
Well-characterized small molecules are essential tools for studying the biology and therapeutic relevance of a target protein. However, many compounds reported in the literature and routinely studied in biomedical research lack the potency and selectivity required for mechanistic cellular studies on the function of a given protein. Furthermore, commercially available compounds often do not include useful tools developed by industry as part of their research and development efforts, as they frequently remain proprietary. The freely available donated chemical probe (DCP) library, fueled by generous donations of compounds from industry and academia, enables easy access to a steadily growing collection of these valuable and well-characterized tools. Here, we provide a systematic description of the current DCP library collection and their associated comprehensive characterization data, including a variety of in vitro and cellular assays. Of note, we characterized the set in relevant human primary models by employing hepatotoxicity screening in primary human liver spheroids and viability screening in patient-derived colorectal cancer organoids and matched normal-adjacent epithelium. Taken together, the DCP library represents a well-annotated, openly available collection of tool compounds for studying a wide range of targets, including kinases, G-protein-coupled receptors, and ion channels. As such, it represents a unique resource for the biomedical research community.
- Published
- 2023
- Full Text
- View/download PDF
32. Bioengineered Pancreas-Liver Crosstalk in a Microfluidic Coculture Chip Identifies Human Metabolic Response Signatures in Prediabetic Hyperglycemia.
- Author
-
Zandi Shafagh R, Youhanna S, Keulen J, Shen JX, Taebnia N, Preiss LC, Klein K, Büttner FA, Bergqvist M, van der Wijngaart W, and Lauschke VM
- Subjects
- Humans, Microfluidics, Liver, Pancreas, Glucose, Diabetes Mellitus, Type 2
- Abstract
Aberrant glucose homeostasis is the most common metabolic disturbance affecting one in ten adults worldwide. Prediabetic hyperglycemia due to dysfunctional interactions between different human tissues, including pancreas and liver, constitutes the largest risk factor for the development of type 2 diabetes. However, this early stage of metabolic disease has received relatively little attention. Microphysiological tissue models that emulate tissue crosstalk offer emerging opportunities to study metabolic interactions. Here, a novel modular multitissue organ-on-a-chip device is presented that allows for integrated and reciprocal communication between different 3D primary human tissue cultures. Precisely controlled heterologous perfusion of each tissue chamber is achieved through a microfluidic single "synthetic heart" pneumatic actuation unit connected to multiple tissue chambers via specific configuration of microchannel resistances. On-chip coculture experiments of organotypic primary human liver spheroids and intact primary human islets demonstrate insulin secretion and hepatic insulin response dynamics at physiological timescales upon glucose challenge. Integration of transcriptomic analyses with promoter motif activity data of 503 transcription factors reveals tissue-specific interacting molecular networks that underlie β-cell stress in prediabetic hyperglycemia. Interestingly, liver and islet cultures show surprising counter-regulation of transcriptional programs, emphasizing the power of microphysiological coculture to elucidate the systems biology of metabolic crosstalk., (© 2022 The Authors. Advanced Science published by Wiley-VCH GmbH.)
- Published
- 2022
- Full Text
- View/download PDF
33. Enzymatically dissociated muscle fibers display rapid dedifferentiation and impaired mitochondrial calcium control.
- Author
-
Gineste C, Youhanna S, Vorrink SU, Henriksson S, Hernández A, Cheng AJ, Chaillou T, Buttgereit A, Schneidereit D, Friedrich O, Hultenby K, Bruton JD, Ivarsson N, Sandblad L, Lauschke VM, and Westerblad H
- Abstract
Cells rapidly lose their physiological phenotype upon disruption of their extracellular matrix (ECM)-intracellular cytoskeleton interactions. By comparing adult mouse skeletal muscle fibers, isolated either by mechanical dissection or by collagenase-induced ECM digestion, we investigated acute effects of ECM disruption on cellular and mitochondrial morphology, transcriptomic signatures, and Ca
2+ handling. RNA-sequencing showed striking differences in gene expression patterns between the two isolation methods with enzymatically dissociated fibers resembling myopathic phenotypes. Mitochondrial appearance was grossly similar in the two groups, but 3D electron microscopy revealed shorter and less branched mitochondria following enzymatic dissociation. Repeated contractions resulted in a prolonged mitochondrial Ca2+ accumulation in enzymatically dissociated fibers, which was partially prevented by cyclophilin inhibitors. Of importance, muscle fibers of mice with severe mitochondrial myopathy show pathognomonic mitochondrial Ca2+ accumulation during repeated contractions and this accumulation was concealed with enzymatic dissociation, making this an ambiguous method in studies of native intracellular Ca2+ fluxes., Competing Interests: The laboratory of H.W. received financial support from NeuroVive Pharmaceutical AB (current name: Abliva AB). V.M.L. is CEO and shareholder of HepaPredict AB, co-founder and shareholder of PersoMedix AB, and discloses consultancy work for EnginZyme AB., (© 2022 The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
34. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives.
- Author
-
Youhanna S, Kemas AM, Preiss L, Zhou Y, Shen JX, Cakal SD, Paqualini FS, Goparaju SK, Shafagh RZ, Lind JU, Sellgren CM, and Lauschke VM
- Subjects
- Drug Development, Drug Evaluation, Preclinical, Humans, Multicenter Studies as Topic, Drug Discovery, Drug-Related Side Effects and Adverse Reactions
- Abstract
The number of successful drug development projects has been stagnant for decades despite major breakthroughs in chemistry, molecular biology, and genetics. Unreliable target identification and poor translatability of preclinical models have been identified as major causes of failure. To improve predictions of clinical efficacy and safety, interest has shifted to three-dimensional culture methods in which human cells can retain many physiologically and functionally relevant phenotypes for extended periods of time. Here, we review the state of the art of available organotypic culture techniques and critically review emerging models of human tissues with key importance for pharmacokinetics, pharmacodynamics, and toxicity. In addition, developments in bioprinting and microfluidic multiorgan cultures to emulate systemic drug disposition are summarized. We close by highlighting important trends regarding the fabrication of organotypic culture platforms and the choice of platform material to limit drug absorption and polymer leaching while supporting the phenotypic maintenance of cultured cells and allowing for scalable device fabrication. We conclude that organotypic and microphysiological human tissue models constitute promising systems to promote drug discovery and development by facilitating drug target identification and improving the preclinical evaluation of drug toxicity and pharmacokinetics. There is, however, a critical need for further validation, benchmarking, and consolidation efforts ideally conducted in intersectoral multicenter settings to accelerate acceptance of these novel models as reliable tools for translational pharmacology and toxicology. SIGNIFICANCE STATEMENT: Organotypic and microphysiological culture of human cells has emerged as a promising tool for preclinical drug discovery and development that might be able to narrow the translation gap. This review discusses recent technological and methodological advancements and the use of these systems for hit discovery and the evaluation of toxicity, clearance, and absorption of lead compounds., (Copyright © 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
35. Organotypic human ex vivo models for coronavirus disease 2019 research and drug development.
- Author
-
Youhanna S, Wright SC, and Lauschke VM
- Subjects
- Drug Development, Humans, Intestines, Kidney, Liver, Organoids, Respiratory System, Models, Biological, SARS-CoV-2, COVID-19 Drug Treatment
- Abstract
Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2019, intense research efforts on an unprecedented scale have focused on the study of viral entry mechanisms and adaptive immunity. While the identification of angiotensin-converting enzyme 2 (ACE2) and other co-receptors has elucidated the molecular and structural basis for viral entry, the pathobiological mechanisms of SARS-CoV-2 in human tissues are less understood. Recent advances in bioengineering have opened opportunities for the use of organotypic human tissue models to investigate host-virus interactions and test antiviral drug candidates in a physiological context. Although it is too early to accurately quantify the added value of these systems compared with conventional cell systems, it can be assumed that these advanced three-dimensional (3D) models contribute toward improved result translation. This mini-review summarizes recent work to study SARS-CoV-2 infection in human 3D tissue models with an emphasis on the pharmacological tools that have been developed to understand and prevent viral entry and replication., Competing Interests: Conflict of interest statement V.M.L. is the CEO and shareholder of HepaPredict AB and co-founder and shareholder of PersoMedix AB. In addition, V.M.L. discloses consultancy work for Enginzyme AB. The other authors declare no conflicts of interest., (Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
36. Uromodulin, Salt, and 24-Hour Blood Pressure in the General Population.
- Author
-
Ponte B, Pruijm M, Ackermann D, Olinger E, Youhanna S, Vogt B, Burnier M, Pechere-Bertschi A, Bochud M, and Devuyst O
- Subjects
- Humans, Blood Pressure, Sodium Chloride, Dietary urine, Uromodulin urine
- Published
- 2021
- Full Text
- View/download PDF
37. Insulin-dependent glucose consumption dynamics in 3D primary human liver cultures measured by a sensitive and specific glucose sensor with nanoliter input volume.
- Author
-
Kemas AM, Youhanna S, Zandi Shafagh R, and Lauschke VM
- Subjects
- Biosensing Techniques, Calibration, Cells, Cultured, Glucose analysis, Glucose Clamp Technique, High-Throughput Screening Assays, Humans, Insulin Resistance, Spheroids, Cellular, Glucose metabolism, Insulin pharmacology, Liver metabolism
- Abstract
The liver plays a central role in glucose homeostasis and hepatic insulin resistance constitutes a key feature of type 2 diabetes. However, platforms that accurately mimic human hepatic glucose disposition and allow for rapid and scalable quantification of glucose consumption dynamics are lacking. Here, we developed and optimized a colorimetric glucose assay based on the glucose oxidase-peroxidase system and demonstrate that the system can monitor glucose consumption in 3D primary human liver cell cultures over multiple days. The system was highly sensitive (limit of detection of 3.5 µM) and exceptionally accurate (R
2 = 0.999) while requiring only nanoliter input volumes (250 nL), enabling longitudinal profiling of individual liver microtissues. By utilizing a novel polymer, off-stoichiometric thiol-ene (OSTE), and click-chemistry based on thiol-Michael additions, we furthermore show that the assay can be covalently bound to custom-build chips, facilitating the integration of the sensor into microfluidic devices. Using this system, we find that glucose uptake of our 3D human liver cultures closely resembles human hepatic glucose uptake in vivo as measured by euglycemic-hyperinsulinemic clamp. By comparing isogenic insulin-resistant and insulin-sensitive liver cultures we furthermore show that insulin and extracellular glucose levels account for 55% and 45% of hepatic glucose consumption, respectively. In conclusion, the presented data show that the integration of accurate and scalable nanoliter glucose sensors with physiologically relevant organotypic human liver models enables longitudinal profiling of hepatic glucose consumption dynamics that will facilitate studies into the biology and pathobiology of glycemic control, as well as antidiabetic drug screening., (© 2021 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.)- Published
- 2021
- Full Text
- View/download PDF
38. Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.
- Author
-
Monteil V, Dyczynski M, Lauschke VM, Kwon H, Wirnsberger G, Youhanna S, Zhang H, Slutsky AS, Hurtado Del Pozo C, Horn M, Montserrat N, Penninger JM, and Mirazimi A
- Subjects
- Adenosine Monophosphate pharmacology, Alanine pharmacology, Animals, Cells, Cultured, Chlorocebus aethiops, Drug Synergism, Humans, Models, Molecular, Recombinant Proteins pharmacology, SARS-CoV-2 physiology, Vero Cells, Virus Internalization drug effects, Virus Replication drug effects, Adenosine Monophosphate analogs & derivatives, Alanine analogs & derivatives, Angiotensin-Converting Enzyme 2 pharmacology, Antiviral Agents pharmacology, SARS-CoV-2 drug effects, COVID-19 Drug Treatment
- Abstract
There is a critical need for safe and effective drugs for COVID-19. Only remdesivir has received authorization for COVID-19 and has been shown to improve outcomes but not decrease mortality. However, the dose of remdesivir is limited by hepatic and kidney toxicity. ACE2 is the critical cell surface receptor for SARS-CoV-2. Here, we investigated additive effect of combination therapy using remdesivir with recombinant soluble ACE2 (high/low dose) on Vero E6 and kidney organoids, targeting two different modalities of SARS-CoV-2 life cycle: cell entry via its receptor ACE2 and intracellular viral RNA replication. This combination treatment markedly improved their therapeutic windows against SARS-CoV-2 in both models. By using single amino-acid resolution screening in haploid ES cells, we report a singular critical pathway required for remdesivir toxicity, namely, Adenylate Kinase 2. The data provided here demonstrate that combining two therapeutic modalities with different targets, common strategy in HIV treatment, exhibit strong additive effects at sub-toxic concentrations. Our data lay the groundwork for the study of combinatorial regimens in future COVID-19 clinical trials., (© 2020 The Authors. Published under the terms of the CC BY 4.0 license.)
- Published
- 2021
- Full Text
- View/download PDF
39. The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies.
- Author
-
Youhanna S and Lauschke VM
- Subjects
- Caco-2 Cells, Humans, Intestinal Absorption, Intestines, Permeability, Intestinal Mucosa metabolism, Pharmaceutical Preparations metabolism
- Abstract
The intestinal epithelium acts as a selective barrier for the absorption of water, nutrients and orally administered drugs. To evaluate the gastrointestinal permeability of a candidate molecule, scientists and drug developers have a multitude of cell culture models at their disposal. Static transwell cultures constitute the most extensively characterized intestinal in vitro system and can accurately categorize molecules into low, intermediate and high permeability compounds. However, they lack key aspects of intestinal physiology, including the cellular complexity of the intestinal epithelium, flow, mechanical strain, or interactions with intestinal mucus and microbes. To emulate these features, a variety of different culture paradigms, including microfluidic chips, organoids and intestinal slice cultures have been developed. Here, we provide an updated overview of intestinal in vitro cell culture systems and critically review their suitability for drug absorption studies. The available data show that these advanced culture models offer impressive possibilities for emulating intestinal complexity. However, there is a paucity of systematic absorption studies and benchmarking data and it remains unclear whether the increase in model complexity and costs translates into improved drug permeability predictions. In the absence of such data, conventional static transwell cultures remain the current gold-standard paradigm for drug absorption studies., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
40. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.
- Author
-
Stebbing J, Sánchez Nievas G, Falcone M, Youhanna S, Richardson P, Ottaviani S, Shen JX, Sommerauer C, Tiseo G, Ghiadoni L, Virdis A, Monzani F, Rizos LR, Forfori F, Avendaño Céspedes A, De Marco S, Carrozzi L, Lena F, Sánchez-Jurado PM, Lacerenza LG, Cesira N, Caldevilla Bernardo D, Perrella A, Niccoli L, Méndez LS, Matarrese D, Goletti D, Tan YJ, Monteil V, Dranitsaris G, Cantini F, Farcomeni A, Dutta S, Burley SK, Zhang H, Pistello M, Li W, Romero MM, Andrés Pretel F, Simón-Talero RS, García-Molina R, Kutter C, Felce JH, Nizami ZF, Miklosi AG, Penninger JM, Menichetti F, Mirazimi A, Abizanda P, and Lauschke VM
- Subjects
- Adult, Aged, Aged, 80 and over, COVID-19 metabolism, COVID-19 virology, Cytokine Release Syndrome, Cytokines metabolism, Drug Evaluation, Preclinical, Female, Gene Expression Profiling, Humans, Interferon alpha-2 metabolism, Italy, Janus Kinases metabolism, Liver drug effects, Male, Middle Aged, Patient Safety, Platelet Activation, Proportional Hazards Models, RNA-Seq, Spain, Virus Internalization drug effects, COVID-19 Drug Treatment, Antiviral Agents pharmacology, Azetidines pharmacology, COVID-19 mortality, Enzyme Inhibitors pharmacology, Janus Kinases antagonists & inhibitors, Liver virology, Purines pharmacology, Pyrazoles pharmacology, SARS-CoV-2 pathogenicity, Sulfonamides pharmacology
- Abstract
Using AI, we identified baricitinib as having antiviral and anticytokine efficacy. We now show a 71% (95% CI 0.15 to 0.58) mortality benefit in 83 patients with moderate-severe SARS-CoV-2 pneumonia with few drug-induced adverse events, including a large elderly cohort (median age, 81 years). An additional 48 cases with mild-moderate pneumonia recovered uneventfully. Using organotypic 3D cultures of primary human liver cells, we demonstrate that interferon-α2 increases ACE2 expression and SARS-CoV-2 infectivity in parenchymal cells by greater than fivefold. RNA-seq reveals gene response signatures associated with platelet activation, fully inhibited by baricitinib. Using viral load quantifications and superresolution microscopy, we found that baricitinib exerts activity rapidly through the inhibition of host proteins (numb-associated kinases), uniquely among antivirals. This reveals mechanistic actions of a Janus kinase-1/2 inhibitor targeting viral entry, replication, and the cytokine storm and is associated with beneficial outcomes including in severely ill elderly patients, data that incentivize further randomized controlled trials., (Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).)
- Published
- 2021
- Full Text
- View/download PDF
41. Facile Nanoimprinting of Robust High-Aspect-Ratio Nanostructures for Human Cell Biomechanics.
- Author
-
Zandi Shafagh R, Shen JX, Youhanna S, Guo W, Lauschke VM, van der Wijngaart W, and Haraldsson T
- Abstract
High-aspect-ratio and hierarchically nanostructured surfaces are common in nature. Synthetic variants are of interest for their specific chemical, mechanic, electric, photonic, or biologic properties but are cumbersome in fabrication or suffer from structural collapse. Here, we replicated and directly biofunctionalized robust, large-area, and high-aspect-ratio nanostructures by nanoimprint lithography of an off-stoichiometric thiol-ene-epoxy polymer. We structured-in a single-step process-dense arrays of pillars with a diameter as low as 100 nm and an aspect ratio of 7.2; holes with a diameter of 70 nm and an aspect ratio of >20; and complex hierarchically layered structures, all with minimal collapse and defectivity. We show that the nanopillar arrays alter mechanosensing of human hepatic cells and provide precise spatial control of cell attachment. We speculate that our results can enable the widespread use of high-aspect-ratio nanotopograhy applications in mechanics, optics, and biomedicine.
- Published
- 2020
- Full Text
- View/download PDF
42. Sports balls as potential SARS-CoV-2 transmission vectors.
- Author
-
Pelisser M, Thompson J, Majra D, Youhanna S, Stebbing J, and Davies P
- Abstract
Objects passed from one player to another have not been assessed for their ability to transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that the surface of sport balls, notably a football, tennis ball, golf ball, and cricket ball could not harbour inactivated virus when it was swabbed onto the surface, even for 30 s. However, when high concentrations of 5000 dC/mL and 10,000 dC/mL are directly pipetted onto the balls, it could be detected after for short time periods. Sports objects can only harbour inactivated SARS-CoV-2 under specific, directly transferred conditions, but wiping with a dry tissue or moist 'baby wipe' or dropping and rolling the balls removes all detectable viral traces. This has helpful implications to sporting events., Competing Interests: JS conflicts can be found at: https://www.nature.com/onc/editors. None are relevant here. No other authors declare a conflict., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
43. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
- Author
-
Stebbing J, Krishnan V, de Bono S, Ottaviani S, Casalini G, Richardson PJ, Monteil V, Lauschke VM, Mirazimi A, Youhanna S, Tan YJ, Baldanti F, Sarasini A, Terres JAR, Nickoloff BJ, Higgs RE, Rocha G, Byers NL, Schlichting DE, Nirula A, Cardoso A, and Corbellino M
- Subjects
- Adult, Aged, Antiviral Agents pharmacokinetics, Antiviral Agents therapeutic use, Azetidines pharmacokinetics, Azetidines therapeutic use, COVID-19, Cytokines antagonists & inhibitors, Drug Evaluation, Preclinical, Drug Repositioning, Female, Humans, Intracellular Signaling Peptides and Proteins antagonists & inhibitors, Leukocytes drug effects, Liver, Male, Middle Aged, Protein Kinase Inhibitors pharmacokinetics, Protein Kinase Inhibitors pharmacology, Protein Serine-Threonine Kinases antagonists & inhibitors, Purines, Pyrazoles, SARS-CoV-2, Spheroids, Cellular drug effects, Spheroids, Cellular virology, Sulfonamides pharmacokinetics, Sulfonamides therapeutic use, COVID-19 Drug Treatment, Antiviral Agents pharmacology, Artificial Intelligence, Azetidines pharmacology, Betacoronavirus, Coronavirus Infections drug therapy, Pandemics, Pneumonia, Viral drug therapy, Protein Kinase Inhibitors therapeutic use, Sulfonamides pharmacology
- Abstract
Baricitinib is an oral Janus kinase (JAK)1/JAK2 inhibitor approved for the treatment of rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI) algorithms, to be useful for COVID-19 infection via proposed anti-cytokine effects and as an inhibitor of host cell viral propagation. We evaluated the in vitro pharmacology of baricitinib across relevant leukocyte subpopulations coupled to its in vivo pharmacokinetics and showed it inhibited signaling of cytokines implicated in COVID-19 infection. We validated the AI-predicted biochemical inhibitory effects of baricitinib on human numb-associated kinase (hNAK) members measuring nanomolar affinities for AAK1, BIKE, and GAK. Inhibition of NAKs led to reduced viral infectivity with baricitinib using human primary liver spheroids. These effects occurred at exposure levels seen clinically. In a case series of patients with bilateral COVID-19 pneumonia, baricitinib treatment was associated with clinical and radiologic recovery, a rapid decline in SARS-CoV-2 viral load, inflammatory markers, and IL-6 levels. Collectively, these data support further evaluation of the anti-cytokine and anti-viral activity of baricitinib and support its assessment in randomized trials in hospitalized COVID-19 patients., (© 2020 Eli Lilly and Company Published under the terms of the CC BY 4.0 license.)
- Published
- 2020
- Full Text
- View/download PDF
44. Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity.
- Author
-
Shen JX, Youhanna S, Zandi Shafagh R, Kele J, and Lauschke VM
- Subjects
- Animals, Drug Evaluation, Preclinical, Drug-Related Side Effects and Adverse Reactions, Humans, Pharmacokinetics, Gastrointestinal Tract metabolism, Kidney metabolism, Liver metabolism, Models, Biological, Pharmaceutical Preparations metabolism
- Abstract
Despite extensive breakthroughs in chemistry, molecular biology, and genetics in the last decades, the success rates of drug development projects remain low. To improve predictions of clinical efficacy and safety of new compounds, a plethora of 3D culture methods of human cells have been developed in which the cultured cells retain physiologically and functionally relevant phenotypes for multiple weeks. Here, we critically review current paradigms for organotypic cultures of human liver, gut, and kidney such as perfused microchips, spheroids, and hollow fiber bioreactors and discuss their utility for understanding drug pharmacokinetics, metabolism, and toxicity. Furthermore, bioprinting and the microfluidic integration of different tissue models to mimic systemic drug effects are highlighted as promising technological trends. In the last part of the review, we discuss important considerations regarding the choice of culture substratum material to limit adverse effects such as drug absorption while facilitating the phenotypic maintenance of cultured cells. We conclude that recent advances in organotypic and microphysiological culture models of human tissues can improve drug development and contribute to an amelioration of clinical attrition rates. However, further validation, benchmarking, and consolidation efforts are needed to achieve more widespread dissemination and eventually regulatory acceptance of these novel tools.
- Published
- 2020
- Full Text
- View/download PDF
45. Response to Giem.
- Author
-
Haber M, Doumet-Serhal C, Scheib C, Xue Y, Danecek P, Mezzavilla M, Youhanna S, Martiniano R, Prado-Martinez J, Szpak M, Matisoo-Smith E, Schutkowski H, Mikulski R, Zalloua P, Kivisild T, and Tyler-Smith C
- Subjects
- Bible
- Published
- 2018
- Full Text
- View/download PDF
46. Genome-Wide Meta-Analysis Unravels Interactions between Magnesium Homeostasis and Metabolic Phenotypes.
- Author
-
Corre T, Arjona FJ, Hayward C, Youhanna S, de Baaij JHF, Belge H, Nägele N, Debaix H, Blanchard MG, Traglia M, Harris SE, Ulivi S, Rueedi R, Lamparter D, Macé A, Sala C, Lenarduzzi S, Ponte B, Pruijm M, Ackermann D, Ehret G, Baptista D, Polasek O, Rudan I, Hurd TW, Hastie ND, Vitart V, Waeber G, Kutalik Z, Bergmann S, Vargas-Poussou R, Konrad M, Gasparini P, Deary IJ, Starr JM, Toniolo D, Vollenweider P, Hoenderop JGJ, Bindels RJM, Bochud M, and Devuyst O
- Subjects
- Adiposity genetics, Animals, GTP-Binding Proteins genetics, Gene-Environment Interaction, Genome-Wide Association Study, Humans, Insulin blood, Insulin Resistance genetics, Magnesium administration & dosage, Mice, Obesity genetics, Phenotype, Polymorphism, Single Nucleotide, RNA, Messenger metabolism, Zebrafish, Zebrafish Proteins genetics, ADP-Ribosylation Factors genetics, Homeostasis genetics, Kidney metabolism, Magnesium blood, Magnesium urine, TRPM Cation Channels genetics
- Abstract
Magnesium (Mg
2+ ) homeostasis is critical for metabolism. However, the genetic determinants of the renal handling of Mg2+ , which is crucial for Mg2+ homeostasis, and the potential influence on metabolic traits in the general population are unknown. We obtained plasma and urine parameters from 9099 individuals from seven cohorts, and conducted a genome-wide meta-analysis of Mg2+ homeostasis. We identified two loci associated with urinary magnesium (uMg), rs3824347 ( P= 4.4×10-13 ) near TRPM6 , which encodes an epithelial Mg2+ channel, and rs35929 ( P= 2.1×10-11 ), a variant of ARL15 , which encodes a GTP-binding protein. Together, these loci account for 2.3% of the variation in 24-hour uMg excretion. In human kidney cells, ARL15 regulated TRPM6-mediated currents. In zebrafish, dietary Mg2+ regulated the expression of the highly conserved ARL15 ortholog arl15b , and arl15b knockdown resulted in renal Mg2+ wasting and metabolic disturbances. Finally, ARL15 rs35929 modified the association of uMg with fasting insulin and fat mass in a general population. In conclusion, this combined observational and experimental approach uncovered a gene-environment interaction linking Mg2+ deficiency to insulin resistance and obesity., (Copyright © 2018 by the American Society of Nephrology.)- Published
- 2018
- Full Text
- View/download PDF
47. Continuity and Admixture in the Last Five Millennia of Levantine History from Ancient Canaanite and Present-Day Lebanese Genome Sequences.
- Author
-
Haber M, Doumet-Serhal C, Scheib C, Xue Y, Danecek P, Mezzavilla M, Youhanna S, Martiniano R, Prado-Martinez J, Szpak M, Matisoo-Smith E, Schutkowski H, Mikulski R, Zalloua P, Kivisild T, and Tyler-Smith C
- Subjects
- Genetic Variation genetics, History, Ancient, Humans, Lebanon, Linkage Disequilibrium, Male, White People genetics, DNA, Mitochondrial genetics, Ethnicity genetics, Genetics, Population methods, Genome, Human genetics
- Abstract
The Canaanites inhabited the Levant region during the Bronze Age and established a culture that became influential in the Near East and beyond. However, the Canaanites, unlike most other ancient Near Easterners of this period, left few surviving textual records and thus their origin and relationship to ancient and present-day populations remain unclear. In this study, we sequenced five whole genomes from ∼3,700-year-old individuals from the city of Sidon, a major Canaanite city-state on the Eastern Mediterranean coast. We also sequenced the genomes of 99 individuals from present-day Lebanon to catalog modern Levantine genetic diversity. We find that a Bronze Age Canaanite-related ancestry was widespread in the region, shared among urban populations inhabiting the coast (Sidon) and inland populations (Jordan) who likely lived in farming societies or were pastoral nomads. This Canaanite-related ancestry derived from mixture between local Neolithic populations and eastern migrants genetically related to Chalcolithic Iranians. We estimate, using linkage-disequilibrium decay patterns, that admixture occurred 6,600-3,550 years ago, coinciding with recorded massive population movements in Mesopotamia during the mid-Holocene. We show that present-day Lebanese derive most of their ancestry from a Canaanite-related population, which therefore implies substantial genetic continuity in the Levant since at least the Bronze Age. In addition, we find Eurasian ancestry in the Lebanese not present in Bronze Age or earlier Levantines. We estimate that this Eurasian ancestry arrived in the Levant around 3,750-2,170 years ago during a period of successive conquests by distant populations., (Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
48. Common variants in CLDN14 are associated with differential excretion of magnesium over calcium in urine.
- Author
-
Corre T, Olinger E, Harris SE, Traglia M, Ulivi S, Lenarduzzi S, Belge H, Youhanna S, Tokonami N, Bonny O, Houillier P, Polasek O, Deary IJ, Starr JM, Toniolo D, Gasparini P, Vollenweider P, Hayward C, Bochud M, and Devuyst O
- Subjects
- Animals, Calcium metabolism, Humans, Kidney Tubules metabolism, Magnesium metabolism, Calcium urine, Claudins genetics, Magnesium urine, Polymorphism, Single Nucleotide genetics, Urine chemistry
- Abstract
The nature and importance of genetic factors regulating the differential handling of Ca
2+ and Mg2+ by the renal tubule in the general population are poorly defined. We conducted a genome-wide meta-analysis of urinary magnesium-to-calcium ratio to identify associated common genetic variants. We included 9320 adults of European descent from four genetic isolates and three urban cohorts. Urinary magnesium and calcium concentrations were measured centrally in spot urine, and each study conducted linear regression analysis of urinary magnesium-to-calcium ratio on ~2.5 million single-nucleotide polymorphisms (SNPs) using an additive model. We investigated, in mouse, the renal expression profile of the top candidate gene and its variation upon changes in dietary magnesium. The genome-wide analysis evidenced a top locus (rs172639, p = 1.7 × 10-12 ), encompassing CLDN14, the gene coding for claudin-14, that was genome-wide significant when using urinary magnesium-to-calcium ratio, but not either one taken separately. In mouse, claudin-14 is expressed in the distal nephron segments specifically handling magnesium, and its expression is regulated by chronic changes in dietary magnesium content. A genome-wide approach identified common variants in the CLDN14 gene exerting a robust influence on the differential excretion of Mg2+ over Ca2+ in urine. These data highlight the power of urinary electrolyte ratios to unravel genetic determinants of renal tubular function. Coupled with mouse experiments, these results support a major role for claudin-14, a gene associated with kidney stones, in the differential paracellular handling of divalent cations by the renal tubule.- Published
- 2017
- Full Text
- View/download PDF
49. Validation of Surrogates of Urine Osmolality in Population Studies.
- Author
-
Youhanna S, Bankir L, Jungers P, Porteous D, Polasek O, Bochud M, Hayward C, and Devuyst O
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Biomarkers urine, Cohort Studies, Creatinine blood, Creatinine urine, Female, Glomerular Filtration Rate, Humans, Kidney physiopathology, Male, Middle Aged, Neurophysins metabolism, Osmolar Concentration, Protein Precursors metabolism, Renal Elimination, Renal Insufficiency, Chronic blood, Renal Insufficiency, Chronic metabolism, Renal Insufficiency, Chronic physiopathology, Vasopressins metabolism, Young Adult, Potassium urine, Renal Insufficiency, Chronic urine, Sodium urine, Urea urine, Urine chemistry
- Abstract
Background: The importance of vasopressin and/or urine concentration in various kidney, cardiovascular, and metabolic diseases has been emphasized recently. Due to technical constraints, urine osmolality (Uosm), a direct reflect of urinary concentrating activity, is rarely measured in epidemiologic studies., Methods: We analyzed 2 possible surrogates of Uosm in 4 large population-based cohorts (total n = 4,247) and in patients with chronic kidney disease (CKD, n = 146). An estimated Uosm (eUosm) based on the concentrations of sodium, potassium, and urea, and a urine concentrating index (UCI) based on the ratio of creatinine concentrations in urine and plasma were compared to the measured Uosm (mUosm)., Results: eUosm is an excellent surrogate of mUosm, with a highly significant linear relationship and values within 5% of mUosm (r = 0.99 or 0.98 in each population cohort). Bland-Altman plots show a good agreement between eUosm and mUosm with mean differences between the 2 variables within ±24 mmol/L. This was verified in men and women, in day and night urine samples, and in CKD patients. The relationship of UCI with mUosm is also significant but is not linear and exhibits more dispersed values. Moreover, the latter index is no longer representative of mUosm in patients with CKD as it declines much more quickly with declining glomerular filtration rate than mUosm., Conclusion: The eUosm is a valid marker of urine concentration in population-based and CKD cohorts. The UCI can provide an estimate of urine concentration when no other measurement is available, but should be used only in subjects with normal renal function., (© 2017 S. Karger AG, Basel.)
- Published
- 2017
- Full Text
- View/download PDF
50. Editors' Digest - Basic Science A Wearable Sweat Analyzer for Continuous Electrolyte Monitoring.
- Author
-
Youhanna S and Devuyst O
- Subjects
- Equipment Design, Glucose analysis, Humans, Kidney Failure, Chronic diagnosis, Lactic Acid analysis, Monitoring, Physiologic instrumentation, Monitoring, Physiologic methods, Peritoneal Dialysis adverse effects, Potassium analysis, Potentiometry instrumentation, Sensitivity and Specificity, Sodium analysis, Biosensing Techniques instrumentation, Electrolytes analysis, Kidney Failure, Chronic therapy, Peritoneal Dialysis methods, Sweat chemistry
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.